摘要
目的:探讨血清可溶性肿瘤坏死因子样凋亡微弱诱导剂(sTWEAK)水平在冠状动脉粥样硬化病变中的变化及临床意义。方法:选择166例患者,依据冠状动脉造影结果分为正常对照组52例、轻度病变组30例、中度病变组40例和重度病变组44例,于入院第1天空腹抽血检测sTWEAK浓度及血脂、超敏C-反应蛋白(hs-CRP)等指标,应用统计学方法探讨这些指标与冠脉病变严重程度的关系。结果:冠脉重度病变组患者血hs-CRP、低密度脂蛋白(LDL-C)、三酰甘油(TG)等显著高于其余三组,HDL水平则在重度病变组明显降低。随着冠脉病变程度加重,sTWEAK浓度逐渐增高。急性冠脉综合征患者外周血sTWEAK水平与冠状动脉粥样硬化严重程度呈正相关。结论:血sTWEAK浓度可能是评价冠心病患者冠脉病变严重程度的指标之一。
Objective To study on serum soluble tumor necrosis factor-lke weak inducer of apoptosis(Stweak) levels in coronary atherosclerosis and its clinical significance.Methods 166 cases with acute coronary syndrome(ACS) were divided into 4 treatment groups:52 cases in control group,30 cases in mild lesions group,40 cases in moderate lesions group,and 44 cases in severe lesions group.Serum sTWEAK concentration was determined by ELISA.Severity of coronary atherosclerosis was estimated by Gensini scoring.Results Serum hs-CRP、LDL-C、TG and sTWEAK concentration are significantly increased in severe lesions group compared with those in other groups.The sTWEAK concentration had a positive correlation with severity of coronary atherosclerosis.Conclusion Evaluation of the serum sTWEAK concentration may be one of the indicators of the severity of coronary lesion in patients with coronary atherosclerotic heart disease.
出处
《吉林医学》
CAS
2014年第18期3907-3909,共3页
Jilin Medical Journal
基金
广西科学研究与技术开发计划课题[课题编号:桂攻科1140003A-20]